CollPlant Biotechnologies Ltd New

Research CollPlant Biotechnologies Ltd New (CLGN) on Bullrun: market cap USD 5.29M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCLGN
• ExchangeNASDAQ
• CountryIsrael
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.29M
• Financial periodFY2025
• RevenueUSD 2.37M
• Revenue growth360.4%
• Net income-USD 11.49M
• Free cash flow-USD 9.45M
• Gross margin64.8%

Valuation Snapshot

latest market cap is USD 5.29M.

About CollPlant Biotechnologies Ltd New

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution;

Frequently asked questions

What is CollPlant Biotechnologies Ltd New's market cap?

CollPlant Biotechnologies Ltd New's market capitalization is USD 5.29M.

What does CollPlant Biotechnologies Ltd New do?

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.